Funding for this research was provided by:
Japan’s Agency for Medical Research and Development, AMED (18lk0201055h0003, 18ek0109277h0002)
Text and Data Mining valid from 2019-06-13
Received: 4 December 2018
Accepted: 4 June 2019
First Online: 13 June 2019
Ethics approval and consent to participate
: This study received approval from the Institutional Review Board at Gifu University Hospital, Gifu, Japan. Each patient or patient’s parent signed an informed consent after receiving a summary explaining study procedures. The trial was also registered in the UMIN Clinical Trials Registry (UMIN000016580).
: Each patient or patient’s parent signed a consent for publication.
: M.O. and T.F. received research funding from Nobelpharma. Sirolimus tablets were supplied by Nobelpharma. The other authors declare no competing interests.